Glial role in oxaliplatin-induced neuropathic pain

Experimental Neurology

Volumn 261, Issue , 2014, Pages 22-33

  Di Cesare Mannelli, Lorenzo ^a   Pacini, Alessandra ^a   Micheli, Laura ^a   Tani, Alessia ^a   Zanardelli, Matteo ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Astrocyte; Chemotherapy induced neuropathic pain; Fluorocitrate; Microglia; Minocycline; Neuroprotection

Indexed keywords

FLUOROCITRIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; MINOCYCLINE; OXALIPLATIN; ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; PLATINUM COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; COLD PLATE TEST; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; GLIA CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MORPHOLOGY; MORPHOMETRICS; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; SPINAL CORD DORSAL HORN; VON FREY TEST; ANIMAL; BODY WEIGHT; CELL COUNT; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GLIA; HYPERALGESIA; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NEURALGIA; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; SPINAL GANGLION; SPRAGUE DAWLEY RAT; TIME; ANALGESIA; CELL ACTIVITY; CELL DENSITY; CELL FUNCTION; COLD SENSITIVITY; DRUG INDUCED DISEASE; HYPERSENSITIVITY; MOTOR COORDINATION; PAIN THRESHOLD;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CALCIUM-BINDING PROTEINS; CELL COUNT; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; HYPERALGESIA; MALE; MICROFILAMENT PROTEINS; MINOCYCLINE; MOTOR ACTIVITY; NEURALGIA; NEUROGLIA; NEURONS; ORGANOPLATINUM COMPOUNDS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; TIME FACTORS;

EID: 84905265673     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.06.016     Document Type: Article

References (69)

1. Albers J.W., Chaudry V., Cavaletti G., Donehower R.C. Intervention for preventive neuropathy caused by cisplatin and related compound. Cochrane Database Syst. Rev. 2011, CD005228.
2. Boivin A., Pineau I., Barrette B., Filali M., Vallie'res N., Rivest S., Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 2007, 27:12565-12576.
3. Boyette-Davis J., Dougherty P.M. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp. Neurol. 2011, 229:353-357.
4. Calvo M., Bennett D.L. The mechanisms of microgliosis and pain following peripheral nerve injury. Exp. Neurol. 2011, 234:271-282.
5. Castellano B., Gonzales B., Jensen M.B., Pedersen E.B., Finsen B.R., Zimmer J. A double staining technique for simultaneous demonstration of astrocytes and microglia in brain sections and astroglial cell cultures. J. Histochem. Cytochem. 1991, 39:561-568.
6. Cavaletti G., Tredici G., Petruccioli M.G., Dondè E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M., Etienne G.G. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 2001, 37:2457-2463.
7. Chen J., Zhang Y., Zhao L., Yuan X., Nie J., Li Z., Ma Y., Zhang Q., Wang Y., Chen Y., Jin Z. Rao Hyperalgesia in response to traumatic occlusion and GFAP expression in rat parabrachial [correction of parabranchial] nucleus: modulation with fluorocitrate. Cell Tissue Res. 2007, 329:231-237.
8. Coggeshall R.E., La Forte R., Klen C.M. Calibration of methods for determining numbers of dorsal root ganglia cells. J. Neurosci. Methods 1990, 35:187-194.
9. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidy J., Boni C., Cortes-Funes H., Cervantes A., Freyer G., Papamichael D., Le Bail N., Louvet C., Hendler D., de Braud F., Wilson C., Morvan F., Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J. Clin. Oncol. 2000, 18:2938-2947.
10. Di Cesare Mannelli L., Zanardelli M., Failli P., Ghelardini C. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. J. Pain 2012, 13:276-284.
11. Di Cesare Mannelli L., Bonaccini L., Mello T., Zanardelli M., Pacini A., Ghelardini C. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. J Pain 2013, 14:1585-1600.
12. Di Cesare Mannelli L., Pacini A., Matera C., Zanardelli M., Mello T., De Amici M., Dallanoce C., Ghelardini C. Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation. Neuropharmacol 2013, 79C:37-48.
13. Di Cesare Mannelli L., Zanardelli M., Ghelardini C. Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models. Eur. J. Pharmacol. 2013, 711:87-94.
14. Drouin-Ouellet J., Brownell A.L., Saint-Pierre M., Fasano C., Emond V., Trudeau L.E., Lévesque D., Cicchetti F. Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions. Glia 2011, 59:188-199.
15. Fallon M.T. Neuropathic pain in cancer. Br. J. Anaesth. 2013, 111:105-111.
16. Fitch M.T., Doller C., Combs C.K., Landreth G.E., Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 1999, 19:8182-8198.
17. Fonnum F., Johnsen A., Hassel B. Use of fluorocitrate and fluoroacetate in the study of brain metabolism. Glia 1997, 21:106-113.
18. Freireich E.J., Gehan E.A., Rall D.P., Schmidt L.H., Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 1996, 50:219-244.
19. Gao Y.J., Ji R.R. Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia. J. Neurochem. 2010, 115:505-514.
20. Graeber M.B., Christie M.J. Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Exp. Neurol. 2012, 234:255-261.
21. Gwak Y.S., Kang J., Unabia G.C., Hulsebosch C.E. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp. Neurol. 2012, 234(2):362-372.
22. Hains B.C., Waxman S.G. Activated microglia contributes to the maintenance of chronic pain after spinal cord injury. J. Neurosci. 2006, 26:4308-4317.
23. Hassel B., Paulsen R.E., Johnsen A., Fonnum F. Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res. 1992, 576:120-124.
24. Hayakawa K., Nakano T., Irie K., Higuchi S., Fujioka M., Orito K., Iwasaki K., Jin G., Lo E.H., Mishima K., Fujiwara M. Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 2010, 30:871-882.
25. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006, 86:1009-1031.
26. He Y., Appel S., Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 2001, 909:187-193.
27. Holmes J., Stanko J., Varchenko M., Ding H., Madden V.J., Bagnell C.R., Wyrick S.D., Chaney S.G. Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. Toxicol. Sci. 1998, 46:342-351.
28. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur. J. Neurosci. 2005, 22:2431-2440.
29. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 1998, 57:1-9.
30. Jacobs S.S., Fox E., Dennie C., Morgan L.B., McCully C.L., Balis F.M. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin. Cancer Res. 2005, 11:1669-1674.
31. Jacobs S.S., McCully C.L., Murphy R.F., Bacher J., Balis F.M., Fox E. Extracellular fluid concentrations of cisplatin, carboplatin and oxaliplatin in brain, muscle and blood measured using microdialysis in nonhuman primates. Cancer Chemother. Pharmacol. 2010, 65:817-824.
32. Kaley T.J., Deangelis L.M. Therapy of chemotherapy-induced peripheral neuropathy. Br. J. Haematol. 2009, 145:3-14.
33. Kyrkanides S., Olschowka J.A., Williams J.P., Hansen J.T., O'Banion M.K. TNF alpha and IL-1beta mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury. J. Neuroimmunol. 1999, 95:95-106.
34. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 15:71-83.
35. Leighton G.E., Rodriguez R.E., Hill R.G., Hughes J. k-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br. J. Pharmacol. 1988, 93:553-560.
36. Lin C.S., Tsaur M.L., Chen C.C., Wang T.Y., Lin C.F., Lai Y.L., Hsu T.C., Pan Y.Y., Yang C.H., Cheng J.K. Chronic intrathecal infusion of minocycline prevents the development of spinal-nerve ligation-induced pain in rats. Reg. Anesth. Pain Med. 2007, 32:209-216.
37. Luongo L., Guida F., Boccella S., Bellini G., Gatta L., Rossi F., de Novellis V., Maione S. Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice. CNS Neurol. Disord. Drug Targets 2013, 12:45-54.
38. Marchand F., Perretti M., McMahon S.B. Role of the immune system in chronic pain. Nat. Rev. Neurosci. 2005, 6:521-532.
39. Mei X.P., Xu H., Xie C., Ren J., Zhou Y., Zhang H., Xu L.-X. Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci. Res. 2011, 70:305-312.
40. Mika J., Osikowicz M., Makuch W., Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur. J. Pharmacol. 2007, 560:142-149.
41. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10:23-36.
42. Milligan E.D., Twining C., Chacur M., Biedenkapp J., O'Connor K., Poole S., Tracey K., Martin D., Maier S.F., Watkins L.R. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 2003, 23:1026-1040.
43. Muller L.J., Gerritsen Van Der Hoop R., Moorer-Van Delft C.M., Gispen W.H., Roubos E.W. Morphological and electrophysiological study of the effects of cisplatin and ORG2766 on rat spinal ganglia neurons. Cancer Res. 1990, 50:2437-2442.
44. Obata K., Yamanaka H., Fukuoka T., Yi D., Tokunaga A., Hashimoto N., Yoshikawa H., Noguchi K. Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats. Pain 2003, 101:65-77.
45. Ohara P.T., Vit J.P., Bhargava A., Romero M., Sundberg C., Charles A.C., Jasmin L. Gliopathic pain: when satellite glial cells go bad. Neuroscientist 2009, 15:450-463.
46. Oken R.J., McGeer P.L. Schizophrenia: a 100-year retrospective. Am. J. Psychiatry 1995, 152:1692-1693.
47. Osikowicz M., Skup M., Mika J., Makuch W., Czarkowska-Bauch J., Przewlocka B. Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain. Pain 2009, 147:175-186.
48. Paulsen R.E., Contestabile A., Villani L., Fonnum F. An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J. Neurochem. 1987, 48:1377-1385.
49. Qin M., Wang J.J., Cao R., Zhang H., Duan L., Gao B., Xiong Y.F., Chen L.W., Rao Z.R. The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat. Neurosci. Res. 2006, 55:442-450.
50. Raghavendra V., Tanga F., DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 2003, 306:624-630.
51. Reagan-Shaw S., Nihal M., Ahamad N. Dose translation from animal to human studies revisited. FASEB J. 2008, 22:659-661.
52. Renn C.L., Carozzi V.A., Rhee P., Gallop D., Dorsey S.G., Cavaletti G. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol. Pain 2011, 7:29.
53. Sakurai M., Egashira N., Kawashiri T., Yano T., Ikesue H., Oishi R. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Pain 2009, 147:165-174.
54. Sanoff H.K., Carpenter W.R., Martin C.F., Sargent D.J., Meyerhardt J.A., Stürmer T., Fine J.P., Weeks J., Niland J., Kahn K.L., Schymura M.J., Schrag D. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. J. Natl. Cancer Inst. 2012, 104:211-227.
55. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
56. Souglakos J., Mavroudis D., Kakolyris S., Kourousis Ch., Vardakis N., Androulakis N., Agelaki S., Kalbakis K., Tsetis D., Athanasiadis N., Samonis G., Georgoulias V. Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J. Clin. Oncol. 2002, 20:2651-2657.
57. Szerb J.C., Issekutz B. Increase in the stimulation-induced overflow of glutamate by fluoroacetate, a selective inhibitor of the glial tricarboxylic cycle. Brain Res. 1987, 410:116-120.
58. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 2001, 21:2580-2588.
59. Tomiwa K., Nolan C., Cavanagh J.B. The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and morphometry. Acta Neuropathol. 1986, 69:295-308.
60. Tsuda M., Beggs S., Salter M.W., Inoue K. Microglia and intractable chronic pain. Glia 2013, 61:55-61.
61. Wang S., Song L., Tan Y., Ma Y., Tian Y., Jin X., Lim G., Zhang S., Chen L., Mao J. A functional relationship between trigeminal astroglial activation and NR1 expression in a rat model of temporomandibular joint inflammation. Pain Med. 2012, 13:1590-1600.
62. Warwick R.A., Hanani M. The contribution of satellite glial cells to chemotherapy-induced neuropathic pain. Eur. J. Pain 2013, 17:571-580.
63. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 1976, 17:1031-1036.
64. Yoon S.Y., Robinson C.R., Zhang H., Dougherty P.M. Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity. J. Pain 2013, 14:205-214.
65. Yoshioka K., Nisimaru N., Yanai S., Shimoda H., Yamada K. Characteristics of monocarboxylates as energy substrates other than glucose in rat brain slices and the effect of selective glial poisoning - a 31P NMR study. Neurosci. Res. 2000, 36:215-226.
66. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15769-15774.
67. Zhang T., Zhang J., Shi J., Feng Y., Sun Z.S., Li H. Antinociceptive synergistic effect of spinal mGluR2/3 antagonist and glial cells inhibitor on peripheral inflammation-induced mechanical hypersensitivity. Brain Res. Bull. 2009, 79:219-223.
68. Zhang X., Xu Y., Wang J., Zhou Q., Pu S., Jiang W., Du D. The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats. J. Neural Transm. 2011, 119:329-336.
69. Zheng F.Y., Xiao W.H., Bennett G.J. The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 2011, 176:447-454.